Qatar vs Syria: Access to anti-retroviral drugs, female (%)
Qatar
43.0%
in 2024
Syria
41.0%
in 2024
Qatar rank
126th
Syria rank
127th
Access to anti-retroviral drugs, female (%) over time
- Qatar
- Syria
How they compare
Qatar currently reports 43.0% against 41.0% in Syria, a difference of 2.0%.
The two have swapped places 1 time across 17 shared years of data; in 2000 it was Syria ahead.
Qatar ranks 126th and Syria ranks 127th of 141 countries.
Across the 3 decades both report, Qatar averaged higher in 2 and Syria in 1.
Head to head by decade
| Decade | Qatar | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 3.1% | 3.1% | Syria |
| 2010s | 85.2% | 34.2% | 51.0% | Qatar |
| 2020s | 53.0% | 41.4% | 11.6% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Qatar or Syria?
- Qatar, at 43.0% against 41.0% in Syria as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Qatar and Syria?
- 2.0%, with Qatar ahead.
- How many years of comparable data are there for Qatar and Syria?
- 17 years are reported by both, from 2000 to 2024.
- How do Qatar and Syria rank globally for access to anti-retroviral drugs, female?
- Qatar ranks 126th and Syria ranks 127th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.